Market revenue in 2023 | USD 57,204.6 million |
Market revenue in 2030 | USD 98,759.2 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Drug Eluting Stents |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.06% in 2023. Horizon Databook has segmented the North America drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
In 2023, North America dominated the global drug device combination products market. The dominance can be attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on Research & Development (R&D), and the high prevalence of chronic conditions, such as cardiovascular diseases.
As per the CDC, every year about six in 10 American adults suffer from at least one chronic condition that requires specialized care and attention. Moreover, favorable government regulations and reimbursement policies contribute to market dominance. Regulatory bodies such as the FDA ensure rigorous quality standards, assuring healthcare professionals and patients of the safety & effectiveness of various healthcare products, including drug-device combination products.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America drug device combination products market , including forecasts for subscribers. This continent databook contains high-level insights into North America drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account